Tryptamine Based Medication

Baileneu Ma produces a variety of tryptamine based medications for treatment of depression, OCD, PTSD, Bipolar Disorder, Addiction (mainly Alcoholism and Opiate Addiction), Glaucoma and cluster headaches. These drugs can be used in both therapy and on a prescription basis, with a variety of different TBs being used in conjunction with other medications, although care should be taken when combining TB antidepressants and MAOi/SSRI antidepressants in order to avoid. Tryptamine based medicines have been used in Baileneu Ma since the 1980s, but were largely unused in other nations until recent years, given the success of current 3rd gen TB antidepressants. There are currently three generations of TB antidepressants, 1st gen includes: Estranopryn and Indopryn; 2nd gen includes: Ginapryn and Deslopryn; 3rd gen includes: Effizapryn, Trandopryn and Meprosyn.

Estranopryn
Estranopryn (4-PO-Dimethyltryptamine) was the first tryptamine based medication that was licensed in 1986, being prescribed in 5mg doses once a day for treatment of depression and OCD, as well as administered in doses up to 20mg for use in therapy sessions, where it was deemed most effective. Doctors in Baileneu Ma reportedly prescribed Estranopryn in 83% of depression cases, with a double blind survey leading to 62% of participants having moderate relief from symptoms, whereas the placebo only only caused moderate relief in 21% of participants. Notable side-effects include nausea, hypotension, mydriasis and disorientation, in higher doses, side-effects include: hallucinations, euphoria, paranoia and in rarer cases, delirium and panic attacks.

Indopryn
Indopryn (Alpha-Methyltryptamine)